Odyssean »

Tg Therapeutics shares owned by Odyssean

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.7M 32k 54.94

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Tg Therapeutics

BlackRock
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
Geode Capital Management
D. E. Shaw & Co
ClearBridge Advisors
Soleus Capital Management
Congress Asset Management
Jane Street
Goldman Sachs Group
Susquehanna International
Pictet Asset Management Holding SA
Hood River Capital Management
Two Sigma Investments

View all funds holding Tg Therapeutics